Novo Nordisk A/S
- Business
JPMorgan says this new company in the GLP-1 market could rise 45%
JPMorgan thinks Viking Therapeutics could be the next big name in the GLP-1 craze. The firm initiated coverage of the…
Read More » - Business
What Wall Street is watching
Investors want to know if Eli Lilly is seeing the same pricing pressure on its hit weight-loss drug Zepbound that…
Read More »